Low-grade serous ovarian cancer | Clinical Trials Search

151,236 results for “Low-grade serous ovarian cancer”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer

31 participants · First posted Nov 9, 2021

A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

20 participants · First posted May 1, 2024

Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer

150 participants · First posted Apr 3, 2015

Active, not recruiting

Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)

37 participants · First posted Jul 10, 2024

Active, not recruiting

Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer

33 participants · First posted Oct 5, 2020

Active, not recruiting

A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients

16 participants · First posted Nov 12, 2024

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

270 participants · First posted Oct 10, 2023

Not yet recruiting

Continued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

2 participants · First posted Aug 5, 2026

Active, not recruiting

A Study of Avutometinib (VS-6766) V. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer with and Without a KRAS Mutation

225 participants · First posted Nov 12, 2020

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

260 participants · First posted Apr 2, 2014

Page 1 of 12742